CSE Bulletin: New Listing - Pharmala Biotech Holdings Inc. (MDMA)
Tweet
Share
E-mailToronto, Ontario--(Newsfile Corp. -le 10 janvier/January 2022) The common shares of Pharmala Biotech Holdings Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
Pharmala is focused on manufacture of Active Pharmaceutical Ingredients, of the Substituted methylenedioxy- phenethylamines class (MDXX), including 3,4-Methylenedioxymethamphetamine (MDMA). Pharmala also intends to undertake development of novel formulations of MDMA and the MDXX class of compounds, as well as developing novel drug delivery pathways for these molecules.
_________________________________
Les actions ordinaires de Pharmala Biotech Holdings Inc. ont été approuvées pour inscription sur le CSE.
Les documents de cotation et d'information seront disponibles sur www.thecse.com à la date de négociation.
Pharmala se concentre sur la fabrication d'ingrédients pharmaceutiques actifs, de la classe des méthylènedioxyphénéthylamines substituées (« MDXX »), y compris la 3,4-méthylènedioxyméthamphétamine (« MDMA »). Pharmala a également l'intention d'entreprendre le développement de nouvelles formulations de MDMA et de la classe de composés MDXX, ainsi que le développement de nouvelles voies d'administration de médicaments pour ces molécules.
| Issuer/Émetteur: | Pharmala Biotech Holdings Inc. |
| Security Type/Titre: | Common Shares/Actions ordinaires |
| Symbol(s)/Symbole(s): | MDMA |
| Number of securities issued and outstanding/ Titres émis et en circulation: | 82 998 600 |
| Number of Securities reserved for issuance/ Titres réservés pour émission: | 14 026 952 |
| CSE Sector/Catégorie: | Life Sciences/Sciences Biologiques |
| CUSIP: | 71719L 10 6 |
| ISIN: | CA 71719L 10 6 7 |
| Boardlot/Quotité: | 500 |
| Trading Currency/Monnaie de négociation: | CDN$/$CDN |
| Trading Date/Date de negociation: | Le 11 janvier/January 2022 |
| Other Exchanges/Autres marches: | N/A |
| Fiscal Year end /Clôture de l'exercice financier: | le 31 août/August |
| Transfer Agent/Agent des transferts: | Marrelli Trust Company Limited |
The Exchange is accepting Market Maker applications for MDMA. Please email: [email protected]
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: [email protected]
Pour toute question, pour obtenir de linformation supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à ladresse: [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Silver One Commences Microgravity Survey at the Phoenix Silver's 417 High-Grade Silver Target to Test for Potential Dense Metallic Bodies
- 5 Best Meme Coins in 2026: Apeing’s 2,400% ROI Can Turn Pennies Into Millions – Act Before the Next Price Jump
- Space42 and Viasat Sign Binding Agreement to co-found Equatys, Creating the First Shared Space and Ground Infrastructure Platform for Global Direct-to-Device and Advanced MSS Connectivity
Create E-mail Alert Related Categories
Newsfile, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
